Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, IHC, WB
Rabbit
Polyclonal
IgG
Serum, plasma, and other biological fluid samples
9.96 ng/mL
31.25 - 2,000 ng/mL
Serum, plasma, and other biological fluid samples
11.58 ng/mL
31.25 - 2,000 ng/mL
Serum, plasma, and other biological fluid samples
12.62 ng/mL
31.25 - 2,000 ng/mL
Serum, plasma, and other biological fluid samples
0.7 ng/mL
1.56 - 100 ng/mL
Serum, plasma, and other biological fluid samples
6.17 pg/mL
12.5–800 pg/mL
Human coronavirus 229E (HCoV-229E)
ELISA, Neutralization
Human
Monoclonal
IgG1, lambda
SAA2363
Severe acute respiratory syndrome coronavirus (SARS-CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E), Human coronavirus OC43 (HCoV-OC43), Human coronavirus NL63 (HCoV-NL63), Human coronavirus HKU1 (HCoV-HKU1)
ELISA, Neutralization
Human
Monoclonal
IgG1, lambda
76E1
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Neutralization, SPR
Human
Monoclonal
IgG1, kappa
KNIH-88
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, lambda2